Clinical context

Visual acuity alone is insufficient when judging corneal disease or surgery. Topography and tomography, surface regularity, biomechanics, endothelial cell density, quality of vision and stability all matter. After refractive procedures, epithelial healing, dry eye, haze, ectasia and the need for enhancement should be assessed separately.

What was studied

This small longitudinal series examined five-year outcomes of posterior-chamber V4c ICL implantation in a complex population: high myopia, keratoconus or previous penetrating keratoplasty. Thirty eyes of 18 patients were assessed at one, two and five years for refractive performance, complications, intraocular pressure, endothelial cell density, anterior chamber angle and vault. Results were compared with previously published iris-fixated phakic-IOL data rather than a concurrent control group. The central clinical question was whether endothelial safety remains acceptable in corneas that already carry elevated risk.

How the evidence was produced

A cohort study describes how outcomes are associated with an exposure or treatment in an observed clinical population. This design is useful for routine practice, uncommon events and longer follow-up, but it remains vulnerable to confounding by indication, baseline risk differences and missing data. An association should not automatically be interpreted as a causal effect.

Key result At five years, the efficacy index was 0.94 and the safety index was 1.04. Postoperative intraocular pressure was significantly higher than baseline, P=.005. Endothelial cell loss was 3.82% at one year, 5.03% at two years and 11.41% at five years; 92% of eyes lost more cells than expected physiologically. Among eyes losing over 25%, every affected eye at two years and 80% at five years had keratoconus or previous keratoplasty. Loss correlated positively with baseline keratometry and negatively with pachymetry; narrower anterior chamber angles and postoperative vault measures were also associated with endothelial findings. Mean vault was 388 ± 159 μm. No cataract was recorded through five years.

How to interpret the result

Refractive performance persisted, but endothelial loss requires surveillance after keratoplasty and in keratoconus. Correlations do not establish causality or a safe vault threshold. No cataract among 30 eyes cannot exclude a rare event. Historical data provide context but cannot demonstrate V4c superiority because populations may differ.

The result should be understood as an estimate for the population studied, not a promise of an individual outcome. Statistical and clinical significance, absolute and relative effects, and prespecified and exploratory analyses should be distinguished. When several endpoints or subgroups are reported, the prespecified primary endpoint for which the study was designed usually provides the most reliable inference.

Clinical applicability

The study may refine technique selection and informed discussion, but its conclusions depend on baseline corneal shape, stromal thickness, equipment, nomogram and surgeon experience. Applicability requires comparison of these factors and attention to variability, uncommon complications and follow-up duration rather than mean values alone.

Limitations

The cohort contained 30 heterogeneous eyes from 18 patients, with bilateral data challenging independence. There was no control or precise subgroup estimate for high myopia, keratoconus and keratoplasty. Correlations are vulnerable to outliers and multiplicity. Five-year follow-up may have survivor bias. Verify baseline endothelial density, subgroup counts, retention, cell-counting method, pressure medication, angle and vault change, reoperations, confidence intervals, funding and historical-comparator criteria in the full paper.

Beyond the limitations acknowledged by the authors, confidence is affected by sample size, follow-up duration, missing data, choice of comparator and relevance of the outcomes to routine care. Uncommon complications may remain undetected even in a well-conducted study. External validity is reduced when participants, equipment or investigator expertise differ substantially from everyday settings.

What to verify in the source

In the full paper, verify the protocol, eligibility criteria, baseline group characteristics, primary endpoint definition, confidence intervals, adverse events and losses to follow-up. Funding, conflicts of interest, trial registration and consistency between the published analysis and the original plan deserve separate attention. The DOI or source link below provides access to the primary publication for this check.